Taglich Brothers Analyst Report on ALRT in PowerPoint

Leading research firm Taglich Brothers has initiated coverage on ALR Technologies, Inc. (OTCBB: ALRT) with a 12-month price target set at 50 cents. Shares are trading today at 8 cents. ALR maintains a relatively low profile in the investment community, but Taglich apparently sees some substantial upside based on their extensive analyst report.

The chart has been holding a baseline for years at this price point, which we will update in a video stock chart this week. Those closely following ALRT have viewed their investor presentation which showcases the corporate strategies and provides examples of potential market penetration, which could approach $1.4 billion annually. The presentation from a recent investor conference call can be viewed in video format at http://www.otcshowcase.com/alr-technologies-investor-call-video/.

There could be numerous catalysts to drive the company quickly back to the 25 cent price point from November 2011 when ALR announced receiving FDA 510(k) clearance for its Health-e-Connect (HeC) system as a technology for remote diabetes management. The big news that has investors’ eyes open and ears to the ground is for CMS (Centers for Medicare and Medicare Services) to issue a statement regarding mandating electronic strip count. While there are many other drivers that can generate substantial revenue after the upcoming commercial launch of HeC this year, that is clearly the “big daddy” as CMS provides coverage for more than 10 million persons with diabetes each year. ALR’s technology outstrips its limited number of competitors that have FDA clearance in either price or function, leaving it in a very enviable spot should the federal agency take regulatory actions in an attempt to curtail waste associated with diabetes care.

The PDF of the Taglich Report as well as much more pertinent investor information is available on the ALRT website.

The Taglich Brothers’ report on ALR Technologies, Inc. in PowerPoint format:

ALR Technologies (OTCBB: ALRT) Taglich Brothers Analyst Report

View more PowerPoint from Andrew Klips

ALR Technologies (ALRT) Stock Quote and News:

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has been compensated three thousand dollars for one month of consultation and journalism services and to manage an investor relations/awareness program by ALR Technologies. Viper has completed prior service agreements with ALRT Technologies with full disclosure listed on our disclaimer/disclosure page. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

	Hearing Date Set in Blue Calypso Lawsuit Against LivingSocial(0) Blue Calypso Inc. (OTCBB: BCYP), an innovator in digital social advertising, mobile content syndication, and analytics, recently announced a Markman hearing set for August 27, 2013 in its patent infringement case against LivingSocial. Findings from this hearing may encourage settlements or provide insight into the likelihood of a particular outcome. With the success seen by

	Digital Development Group Partners with Hollywood Bad Boy Charlie Sheen(0) One might think that celebrity endorsements would be fantastic for the share price of a small or microcap company. After all, famous and successful athletes or movie stars have a stack of cash to invest and the connections to help accelerate business developments. Oddly, though, it doesn’t seem to have a great deal of impact.

	Sunvalley Solar Shares Rise from Bottom on Solar Installation Contract(0) Shares of Sunvalley Solar, Inc. (OTCBB: SSOL) are rising in trading Monday morning after the solar power technology company disclosed a new contract to 87.5-kilowatt solar system installation contract from Corporate Logistics in City of Industry, California. The contract is for a system capable of generating 131,146 kilowatt hours of electrical power each year, utilizing

	Men’s Health Features Naked Brand Group Line of Underwear(0) Naked Brand Group, Inc. (OTCQB: NAKD) said Friday that its Naked Boxer Brief has been selected by Men’s Health for its online guide, “Affordable Spring Style Guide 100 under $100.” The guide was published on MensHealth.com on March 20. This is the second time the company has been featured in the men’s mag in as

	Sunshine Biopharma Meeting with CMOs to Manufacture Drug for Breast Cancer Trials(0) Sunshine Biopharma Inc. (OTCQB: SBFM) reported on Thursday that it is in negotiations with Contract Manufacturing Organizations, or CMOs, as the next progression towards the anticipated clinical trials of its flagship cancer drug, Adva-27a, against multi-drug resistant forms of breast cancer. The trials are scheduled to be hosted by the leading cancer center Jewish General

Stay Informed

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.